Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
NIH: A Phase I Open-Label Trial To Investigate the Pharmacokinetic Interaction Between Rifabutin Or Rifampin And A Single Dose Of TMC207 In Healthy Subjects
Study Director
Start Date
0 / 0
Trial Phase
Trial Status
published
Current Enrollment
Target Enrollment
32
Overview
Compound Associations
Bedaquiline (TMC207) for DS-TB